International harmonization supports Taiwan’s drug registration by aligning TFDA regulations with global standards, such as those from the International Council for Harmonisation (ICH). This alignment streamlines the use of foreign clinical data and encourages data sharing. Participation in international forums ensures Taiwan’s compliance with GMP and enhances access to new therapies.
